Michael Senior
Senior Director, Diagnostic Partnerships, Oncology Business Unit AstraZeneca
Seminars
Tuesday 31st March 2026
Panel Discussion: Beyond the Microscope: Navigating the Future of Digital Pathology & Computational Biomarkers
9:40 am
- Explore the development and strategic rationale behind the TROP2 NMR computational biomarker
- Discuss how digital pathology and AI can solve large, looming questions in pathology
- Address the key barriers to computational pathology adoption, successful commercialisation and market enablement
